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Abstract 
West Nile neuroinvasive disease (WNND) is a rare and severe manifestation of West Nile virus (WNV) infection 
that occurs in less than 1% of infected persons. It should be considered in patients who present with fever, 
neurological symptoms, and a history of recent outdoor activity where mosquitoes were active. This article 
highlights a case of a 55-year-old man whose history and symptoms of WNND were confounded with an 
alternate diagnosis, acute alcohol withdrawal. An overview of WNV infections, and important historical clues 
and objective findings characteristic of neuroinvasive disease, is discussed to increase readers' knowledge of 
WNV and awareness of when to consider WNND in the diagnostic differential. 
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WEST NILE VIRUS (WNV) was first identified in 1937 in Uganda and has spread across the globe (Montgomery & 
Murray, 2015). In the United States, WNV spread from a focal area in New York City in 1999 to all of the 48 
states, Canada, and south to Argentina (Nasci, 2013). The virus is classified as an arbovirus that has been found 
in mosquitoes, birds, ticks, and a variety of mammal species. There are approximately 1,800 cases of WNV 
infection annually in the United States; most of these infections are mild and self-limiting. Approximately 1% of 
persons infected with WNV develop neuroinvasive disease (Centers for Disease Control and Prevention [CDC], 
2018). West Nile neuroinvasive disease (WNND) is a severe manifestation of infection that occurs primarily in 
very young children, older adults, persons with immunocompromised conditions such as malignancy, organ 
transplant, or chronic steroid use, or those with comorbid conditions including diabetes, hypertension, alcohol 
abuse, and renal disease (CDC, 2018). Other arboviruses can cause neuroinvasive disease; however, WNV is 
responsible for 94% of all cases of neuroinvasive disease in the United States (Krow-Lucal, Lindsey, Lehman, 
Fischer, & Staples, 2017). 
The following case is a report of a 55-year-old man who presented with altered mental status secondary to 
WNND. However, this diagnosis was not identified initially due to a limited history and because his presentation 
was consistent with complications of substance use disorder. Important historical clues and objective findings 
characteristic of neuroinvasive disease are discussed to increase readers' knowledge of WNV and awareness of 
when to consider WNND in the diagnostic differential. 
Case Report 
A 55-year-old Caucasian man presented to the emergency department (ED) via ambulance. He was noted to be 
hypertensive and febrile and had altered mental status. The patient was presented to the medical team and 
seen by the nurse practitioner (NP) on the team. On the NP's initial assessment, the patient was alert and 
oriented to person, place, and time. However, he was agitated throughout the assessment, calling out names 
and acting aggressive toward the staff. The patient had no focal neurological deficits and strength was intact 
5/5 bilaterally in all four extremities. The remainder of his examination was unremarkable. His past medical 
history included polysubstance abuse, nonischemic cardiomyopathy, hypertension, diabetes Type 2, and Stage 
III chronic kidney disease (CKD). He was a current every day one-half pack smoker and had daily polysubstance 
abuse. Of note, the patient reported he had stopped using drugs and drinking "cold turkey" several days before 
coming to the hospital. 
On the basis of his history of alcohol use and short-term period of abstinence, the NP treated him for alcohol 
withdrawal with benzodiazepines, intravenous fluids, a multivitamin, and thiamine. Wernicke's encephalopathy 
was considered a top differential for his altered mental status; thus, he was treated with high-dose vitamin B12. 
No restraints or medications other than those for alcohol withdrawal were used to treat the patient's agitation. 
He was admitted from the ED to a medical-surgical unit in the hospital. 
On hospital Day 3, his mentation deteriorated. Because of increased agitation and decreased orientation, he 
was transferred to the intensive care unit (ICU). Upon arrival to the ICU, a physical examination was performed. 
The patient was noted to be agitated, trying to get out of bed, and physically aggressive toward the staff. He 
was disoriented to person, place, and time. He did have asterixis, which is a hand tremor when wrists are 
extended, and clonus, which is muscular spasm involving repeated contractions. He did not have nystagmus. He 
had 5/5 strength and equal movement in all extremities. The NP was unable to obtain reflexes due to his 
agitation. The rest of his examination was unremarkable. The NP attempted to obtain a more thorough history 
from the patient, but he was unable to provide a cogent history due to his mental status. Of note, the patient 
had been having intermittent fevers since his presentation in the ED. At this point, the NP reconsidered the 
diagnoses of alcohol withdrawal or Wernicke's encephalopathy as the patient's condition had deteriorated 
despite adequate treatment for these two conditions. 
Initial differential diagnosis for the patient's encephalopathy was severe alcohol withdrawal, hypertensive 
emergency, stroke, infection, and seizures. He was sent for a computed tomographic (CT) scan of the head to 
rule out an ischemic or hemorrhagic stroke. Blood cultures, urine culture, and a chest radiograph were obtained 
to evaluate for a source of infection. He was also started on broad-spectrum antibiotics, antihypertensives, 24-
hr continuous electroencephalogram (cEEG), placed in wrist restraints, and a sitter was placed at the bedside 
for his safety. While the patient was at his CT scan, the NP on the critical care team called the patient's 
significant other who stated that the patient had been in a rural setting for a hunting trip prior to his 
hospitalization. Based on this information, the NP's differential diagnosis for his encephalopathy changed to 
include tick and mosquito-borne diseases, including WNV. Neurology was consulted because of the patient's 
deteriorating mental status, and it was recommended to perform a lumbar puncture to evaluate for Lyme 
disease, WNV infection, viral meningitis, and herpes encephalitis. A lumbar puncture was performed the 
evening of the patient's admission to the ICU. The CT scan of the head was negative, cEEG did not reveal seizure 
activity, and the preliminary findings of infectious workup was negative. Given these results, the cEEG and 
broad-spectrum antibiotics were discontinued. The lumbar puncture was positive for WNV AB IgM, which 
confirmed this patient's diagnosis of WNND. 
Currently, there is no treatment for WNV (CDC, 2018; Montgomery & Murray, 2015). Multiple treatments have 
been tested including interferon, ribavirin, and intravenous immunoglobulin; however, none have been shown 
to be effective (National Center for Emerging and Zoonotic Infectious Diseases, 2018). It is a self-limiting 
infection and as such treatment is supportive. The patient's comorbidities were managed (hypertension, 
diabetes, CKD III), and a sitter was placed at the bedside for safety as the patient was agitated. Psychiatry was 
consulted and recommended quetiapine every 2 hr for agitation. Over a week's time, the patient's mentation 




West Nile viral infections in humans are most commonly transmitted via mosquitoes (CDC, 2018). The WNV is 
maintained in a bird-mosquito-bird cycle in which mosquitoes become infected by feeding on infected birds 
(Whitehorn & Yacoub, 2019). West Nile viral infection is not contagious among humans and is not spread via 
respiratory droplet, contact, fomite, or fecal-oral routes. In rare cases, WNV has been transmitted from person 
to person through blood transfusions, organ donation, and exposure in a laboratory setting or from mother to 
infant through pregnancy, delivery, or breastfeeding (CDC, 2018). 
Conditions that promote mosquito infestation include warm climates, rainfall, and stagnant water resources 
(Montgomery & Murray, 2015). However, these conditions exist across the United States, albeit with seasonal 
variation. Since 1996, mild WNV infections have been reported in all of the states in the United States except 
Alaska; neuroinvasive infections have been reported in all states except Alaska and Hawaii. States along the 
Eastern seaboard have the lowest incidence of WNV neuroinvasive infections. Central states roughly bordered 
by the Mississippi River, the Rocky Mountains, and the northern and southern borders of the United States 
have the highest incidences of WNV neuroinvasive infections (CDC, 2018). It is important for health care 
providers to have awareness of WNV infection, for the prevalence may increase as global climate change 
contributes to increased suitable habitat for the mosquitoes that harbor this virus (Whitehorn & Yacoub, 2019). 
Currently, there are vaccines for horses against WNV. There are no vaccines for humans against WNV, although 
researchers are actively working to develop one (National Institute of Allergy and Infectious Diseases, 2015). 
Therefore, risk reduction is geared toward mosquito control including avoidance of mosquito habitats, staying 
indoors when mosquitoes are active, draining stagnant water, utilizing mosquito repellants and protective 
clothing, and utilization of window screens and mosquito netting. 
West Nile Fever 
  
West Nile virus infection is most commonly a self-limiting infection in which the majority of patients are 
asymptomatic (Sejvar et al., 2003). Approximately 20% of patients have a mild, systemic febrile illness 
termed West Nile fever (WNF) (Sejvar, 2014). West Nile fever occurs more commonly among younger 
patients. Incubation period is 2-14 days, followed by an abrupt onset of mild and nonspecific symptoms 
including fever, headache, fatigue, myalgia, nausea and vomiting, lymphadenopathy, and rash (see Table 
1; Sejvar, 2014; Whitehorn & Yacoub, 2019). Rash is more common in WNF than in WNND and is 
morbilliform, maculopapular, and nonpruritic on the torso and extremities and sparing the palms and soles 
(Sejvar, 2014). 
Table 1: Symptoms of acute Alcohol withdrawal compared to WNND infection 
Body system Alcohol withdrawal symptoms WNND 
Constitutional Fever, insomnia, anxiety Fever, malaise, weight loss 
Neurological Tremors, headache, irritability, 
disorientation, diaphoresis, dilated 
pupils, hyperarousal, seizures, paranoia, 
hallucinations 
Tremors, headache, irritability, 
disorientation, weakness, gait 
disturbance, dyskinesia, nuchal rigidity, 
acute flaccid paralysis 
Cardiovascular Palpitations, tachycardia, hypertension Tachycardia, hypertension 
Gastrointestinal Nausea, vomiting, anorexia Nausea, vomiting, anorexia 




Pathogenesis of Signs and Symptoms of Neuroinvasive Disease 
Less than 1% of infected persons develop WNND in which the virus invades the intrathecal space causing 
infection of the structures of the central nervous system (CNS) and neurological symptoms (see Table 1). After 
infection via an insect vector, the WNV replicates in the bloodstream for approximately 1 week before the virus 
becomes detectable in the cerebral spinal fluid (CSF). Presentation of clinical neurological symptoms such as 
encephalitis, meningitis, or acute flaccid paralysis coincides with viral invasion of the CSF (Larrieu et al., 
2013; Lyons, Schaefer, Cho, & Azar, 2017). In previously published case reports, patients with confirmed WNND 
presented with fever, headache, weight loss, weakness, and myalgias; irritability and altered mental status 
were present in some patients or occurred within 12 hr after admission (Larrieu et al., 2013; Lyons et al., 
2017; Sejvar et al., 2003). 
Table 2. Symptoms of West Nile virus neuroinvasive disease 
CNS structure Neurological symptoms Diagnosis 
Meninges Headache, fever, nuchal rigidity, photophobia, 
phonophobia 




Tremor in upper extremities, myoclonus, 
dyskinesia, postural instability, gait disturbance 
West Nile encephalitis 
Lower motor neurons of 
the spinal cord 
Acute and abrupt limb paresis (partial weakness) 
or paralysis, sensory loss, or numbness usually 
absent 
West Nile poliomyelitis or 
acute flaccid paralysis 
Lower brainstem Diaphragmatic and intercostal muscle paralysis, 
neuromuscular respiratory failure 
West Nile poliomyelitis 
 
Neurological manifestations of infection vary depending on which CNS structures are affected (see Table 2). 
 
 
Laboratory Testing and Diagnosis 
Suspected WNND is defined as an acute infectious illness with clinical evidence of meningitis, encephalitis, or 
acute focal weakness (Sejvar et al., 2003). For febrile patients with neurological symptoms, it is essential to 
consider travel history and time spent outdoors. West Nile virus infection should be considered in any person 
with a febrile or acute neurological illness who has had recent exposure to mosquitoes, especially during the 
summer months (CDC, 2018). Serum or CSF can be tested to detect WNV-specific IgM antibodies. When WNV 
invades the CSF, the body mounts a specific humoral immune response that leads to detectable specific 
antibodies within the blood (Lyons et al., 2017). These IgM antibodies are usually detectable 3-8 days after the 
onset of illness and can stay elevated for up to 30-90 days after the initial infection. Onset of symptoms within 8 
days of a positive test is consistent with an acute WNV infection. If the patient had no symptoms within 8 days 
of a positive test, it is likely a past infection (CDC, 2018). Positive results obtained with commercially available 
WNV IgM assays should be confirmed by further testing at a state public health laboratory or CDC. Positive IgG 
antibodies alone indicate past infection. Polymerase chain reaction (PCR) testing for the WNV is of limited use 
in immunocompetent persons because viremia is often resolved when symptoms are present, thus negative 
results do not rule out infection. Polymerase chain reaction testing may be useful in immunocompromised 
patients because viremia may be prolonged and antibody development may be delayed or absent (Nasci et al., 
2013). Viral cultures are less sensitive than PCR and are not recommended. Cases of WNV should be reported to 
public health authorities. 
Prognosis 
Recovery from neuroinvasive disease varies depending on the extent of neurological infection; some patients 
will experience fatigue, malaise, and weakness for weeks or months and eventually recover completely. 
Patients who have had WNV encephalitis or poliomyelitis often have residual neurological deficits (CDC, 2018). 
Complications of neuroinvasive disease include demyelinating neuropathy, parkinsonism symptoms, seizures, 
chorioretinitis, brachial plexopathy, encephalitis, or meningitis (Larrieu et al., 2013). In the United States., death 
occurs in approximately 10% of persons with WNND (CDC, 2018). 
Conclusion 
This case report described a rare, but serious, presentation of a patient with WNND. Approach to differential 
diagnosis typically includes considering the most likely causes of patients' presenting symptoms and history. 
However, to ensure that the differential diagnosis is complete, it is essential to obtain a thorough history. This 
can be difficult when a patient presents with altered mental status. In these cases, if possible, it is best to 
contact family and friends who may be able to provide relevant information. Furthermore, if a patient's 
condition does not improve after treating the working diagnosis, it is important to reconsider the differential 
diagnosis and additional diagnostic testing. In certain cases, it is important to consider rare diagnoses such as 
WNND. 
This case report was done with the patient's permission. 
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